Member Exclusive

Drugs from nature targeting inflammation: in discussion with Atanas Atanasov

MedChemNet discusses DNTI, an interdisciplinary network project with success in identifying novel drug candidates for inflammation, with Atanas Atanasov, one of the project’s collaborators.

Go to the profile of Stella Bennett
Apr 07, 2016

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.